U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H26N2O
Molecular Weight 322.4439
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)BENZENEACETAMIDE, (S)-

SMILES

CN([C@H](CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC=CC=C3

InChI

InChIKey=OVZWUDZIAAHNFG-HXUWFJFHSA-N
InChI=1S/C21H26N2O/c1-22(21(24)16-18-10-4-2-5-11-18)20(17-23-14-8-9-15-23)19-12-6-3-7-13-19/h2-7,10-13,20H,8-9,14-17H2,1H3/t20-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H26N2O
Molecular Weight 322.4439
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15863335 | https://google.com/patents/WO1998049141A1

N-MPPP HYDROCHLORIDE is high-affinity κ agonist with no measured binding at μ or δ sites.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
5.8 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Hartley-VAF Plus guinea pigs were killed by decapitation and the brains removed. The brains, less cerebellum, were homogenized in six volumes of 0.05 M Trizma buffer (pH 7.4) with a Virtrishear homogenizer at a control setting of 70 for three 5 s intervals. The homogenate was centrifuged at 25000g at 40C for 20 min. The pellet was resuspended in six volumes of aqueous 0.32 M sucrose and stored at -70 0C until needed. Frozen homogenate was thawed at room temperature and diluted with 0.05 M Trizma buffer (pH 7.4) to give a final dilution ratio of 1:60 (initial brain weight to total solution volume). Radioligands used were [3H]bremazocine (0.5 nM) for total ligand binding, [3H]DAMG0 (1.0 nM) for preceptor binding, [3H]DPDPE (1.0 nM) for delta- receptor binding, and [3H]U-69,593( 1.0 nM) for kapa-receptor N-MPPP was tested against bremazocine and DPDPE in duplicate at nine concentrations between 1.0 and 1000 nM, N-MPPP tested against [3H]U-69,593 in triplicate at five concentrations between 0.22 and 4.7 nM. Nonspecific binding was measured in the presence of 10 mkM naloxone
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:14:16 GMT 2023
Edited
by admin
on Sat Dec 16 10:14:16 GMT 2023
Record UNII
0G3RS2P5HF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)BENZENEACETAMIDE, (S)-
Systematic Name English
BENZENEACETAMIDE, N-METHYL-N-((1S)-1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)-
Systematic Name English
BENZENEACETAMIDE, N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)-, (S)-
Systematic Name English
N-METHYL-N-((1S)-1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)BENZENEACETAMIDE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90935832
Created by admin on Sat Dec 16 10:14:16 GMT 2023 , Edited by admin on Sat Dec 16 10:14:16 GMT 2023
PRIMARY
CAS
157947-87-0
Created by admin on Sat Dec 16 10:14:16 GMT 2023 , Edited by admin on Sat Dec 16 10:14:16 GMT 2023
PRIMARY
PUBCHEM
190901
Created by admin on Sat Dec 16 10:14:16 GMT 2023 , Edited by admin on Sat Dec 16 10:14:16 GMT 2023
PRIMARY
FDA UNII
0G3RS2P5HF
Created by admin on Sat Dec 16 10:14:16 GMT 2023 , Edited by admin on Sat Dec 16 10:14:16 GMT 2023
PRIMARY